Skip to main content

Checkmate Pharmaceuticals, Inc.

CMPIDelisted May 31, 2022
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001651431

Checkmate Pharmaceuticals, Inc. was delisted on May 31, 2022; its insiders filed their last Form 4 on May 31, 2022; 26 institutions reported holding it in 13F filings for Q1 2022, worth $54.8M in total; no superinvestor held it.

Q2 2021 vs. Q1 2021

How the institutions holding Checkmate Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of CMPI: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders3734−3
Shares16.7M16.3M−361.7K (−2.2%)
Value$202.5M$97.3M−$105.3M (−52.0%)

New holders (9)

Institutions that held Checkmate Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to CMPI in Q2 2021
InstitutionSharesValue% of portfolio
RBF Capital, LLC68,834$410.0K0.02%
Millennium Management LLC40,422$241.0K0.00%
Ergoteles LLC26,427$158.0K0.00%
Alberta Investment Management Corp25,000$149.0K0.00%
HRT Financial LP24,121$143.0K0.00%
Renaissance Technologies LLC23,500$140.0K0.00%
Advisory Services Network, LLC7,800$46.0K0.00%
US Bancorp2,000$12.0K0.00%
Johnson Midwest Financial, LLC200$1.00K0.00%

Sold out (12)

Institutions that held Checkmate Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of CMPI in Q2 2021
InstitutionShares, Q1 2021Value, Q1 2021
State Street Corp83,259$1.01M
Northern Trust Corp81,359$987.0K
STRS Ohio19,300$234.0K
Charles Schwab Investment Management Inc19,146$233.0K
Bank of New York Mellon Corp17,188$208.0K
California State Teachers Retirement System13,503$164.0K
Canada Pension Plan Investment Board10,000$121.0K
American International Group, Inc.5,217$63.0K
Tower Research Capital LLC (TRC)1,976$24.0K
Legal & General Group Plc876$11.0K
Bank of Montreal608$6.00K
Ameritas Investment Partners, Inc.430$5.00K